Lindsey Hartley
Vermogen: 3 M $ op 31-05-2026
Vermogen: 3 M $ op 31-05-2026
Ms. Lindsey Hartley, CPA, is a Chief Financial Officer at Axogen, Inc. Ms. Hartley was previously employed as an Audit Manager by EY LLC and a VP-Finance, Accounting & Human Strategy by Vero Biotech, Inc. She received her undergraduate degree from the University of South Florida.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AXOGEN, INC. 0,12% | 07-05-2026 | 65.146 ( 0,12% ) | 3 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AXOGEN, INC. | Financieel Directeur/CFO | 12-05-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
EY LLC
EY LLC Miscellaneous Commercial ServicesCommercial Services Provides professional services | Comptroller/Controller/Auditor | - |
Vero Biotech, Inc.
Vero Biotech, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that focused on the design, development and commercialization of inhaled nitric oxide delivery systems | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Vero Biotech, Inc.
Vero Biotech, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that focused on the design, development and commercialization of inhaled nitric oxide delivery systems | Health Technology |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axogen, Inc.
Axogen, Inc. Medical SpecialtiesHealth Technology Provides products and technologies for peripheral nerve reconstruction and regeneration | Health Technology |
EY LLC
EY LLC Miscellaneous Commercial ServicesCommercial Services Provides professional services | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau